Phosphoglycerate kinase 1 (PGK1) catalyzes the reversible transfer of a phosphoryl group from 1, 3-bisphosphoglycerate (1, 3-BPG) to ADP, producing 3-phosphoglycerate (3-PG) and ATP. PGK1 plays a key role in coordinating glycolytic energy production with one-carbon metabolism, serine biosynthesis, and cellular redox regulation. Here, we report that PGK1 is acetylated at lysine 220 (K220), which inhibits PGK1 activity by disrupting the binding with its substrate, ADP. We have identified KAT9 and HDAC3 as the potential acetyltransferase and deacetylase, respectively, for PGK1. Insulin promotes K220 deacetylation to stimulate PGK1 activity. We show that the PI3K/AKT/mTOR pathway regulates HDAC3 S424 phosphorylation, which promotes HDAC3-PGK1 interaction and PGK1 K220 deacetylation. Our study uncovers a previously unknown mechanism for the insulin and mTOR pathway in regulation of glycolytic ATP production and cellular redox potential via HDAC3-mediated PGK1 deacetylation.
References
[1]
Scopes RK. Studies with a reconstituted muscle glycolytic system. The rate and extent of creatine phosphorylation by anaerobic glycolysis. The Biochemical journal. 1973;134(1):197–208. \ pmid:4269207 doi: 10.1042/bj1340197
[2]
Fell DA, Snell K. Control analysis of mammalian serine biosynthesis. Feedback inhibition on the final step. The Biochemical journal. 1988;256(1):97–101. pmid:2851987 doi: 10.1042/bj2560097
[3]
Locasale JW. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nature reviews Cancer. 2013;13(8):572–83. doi: 10.1038/nrc3557. pmid:23822983
[4]
Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free radical biology & medicine. 2010;48(6):749–62. doi: 10.1016/j.freeradbiomed.2009.12.022
[5]
Tedeschi PM, Markert EK, Gounder M, Lin H, Dvorzhinski D, Dolfi SC, et al. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell death & disease. 2013;4:e877. doi: 10.1038/cddis.2013.393
[6]
Holland MJ, Holland JP. Isolation and identification of yeast messenger ribonucleic acids coding for enolase, glyceraldehyde-3-phosphate dehydrogenase, and phosphoglycerate kinase. Biochemistry. 1978;17(23):4900–7. pmid:363146 doi: 10.1021/bi00616a007
[7]
Maitra PK, Lobo Z. Control of glycolytic enzyme synthesis in yeast by products of the hexokinase reaction. The Journal of biological chemistry. 1971;246(2):489–99. pmid:4250748
[8]
Goldman GH, Geremia RA, Caplan AB, Vila SB, Villarroel R, Van Montagu M, et al. Molecular characterization and regulation of the phosphoglycerate kinase gene from Trichoderma viride. Molecular microbiology. 1992;6(9):1231–42. pmid:1588821 doi: 10.1111/j.1365-2958.1992.tb01562.x
[9]
Nakajima K, Kunihiro S, Sano M, Zhang Y, Eto S, Chang YC, et al. Comprehensive cloning and expression analysis of glycolytic genes from the filamentous fungus, Aspergillus oryzae. Current genetics. 2000;37(5):322–7. pmid:10853769 doi: 10.1007/s002940050534
[10]
Vassallo N, Galea DR, Bannister WH, Balzan R. Stimulation of yeast 3-phosphoglycerate kinase gene promoter by paraquat. Biochemical and biophysical research communications. 2000;270(3):1036–40. pmid:10772946 doi: 10.1006/bbrc.2000.2566
[11]
Mazzoni C, Torella M, Petrera A, Palermo V, Falcone C. PGK1, the gene encoding the glycolitic enzyme phosphoglycerate kinase, acts as a multicopy suppressor of apoptotic phenotypes in S. cerevisiae. Yeast. 2009;26(1):31–7. doi: 10.1002/yea.1647. pmid:19180641
[12]
Willard HF, Goss SJ, Holmes MT, Munroe DL. Regional localization of the phosphoglycerate kinase gene and pseudogene on the human X chromosome and assignment of a related DNA sequence to chromosome 19. Hum Genet. 1985;71(2):138–43. Epub 1985/01/01. pmid:2995234 doi: 10.1007/bf00283369
[13]
McCarrey JR, Thomas K. Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. Nature. 1987;326(6112):501–5. Epub 1987/04/02. pmid:3453121 doi: 10.1038/326501a0
[14]
Cliff MJ, Bowler MW, Varga A, Marston JP, Szabo J, Hounslow AM, et al. Transition state analogue structures of human phosphoglycerate kinase establish the importance of charge balance in catalysis. J Am Chem Soc. 2010;132(18):6507–16. Epub 2010/04/20. doi: 10.1021/ja100974t. pmid:20397725
[15]
Jang CH, Lee IA, Ha YR, Lim J, Sung MK, Lee SJ, et al. PGK1 induction by a hydrogen peroxide treatment is suppressed by antioxidants in human colon carcinoma cells. Biosci Biotechnol Biochem. 2008;72(7):1799–808. Epub 2008/07/08. pmid:18603805 doi: 10.1271/bbb.80079
[16]
Okino ST, Chichester CH, Whitlock JP Jr. Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter and at an initiator-driven promoter. J Biol Chem. 1998;273(37):23837–43. Epub 1998/09/03. pmid:9726995 doi: 10.1074/jbc.273.37.23837
[17]
Kress S, Stein A, Maurer P, Weber B, Reichert J, Buchmann A, et al. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol. 1998;124(6):315–20. Epub 1998/08/06. pmid:9692838 doi: 10.1007/s004320050175
[18]
Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell. 2006;23(4):607–18. Epub 2006/08/19. pmid:16916647 doi: 10.1016/j.molcel.2006.06.026
[19]
Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325(5942):834–40. Epub 2009/07/18. doi: 10.1126/science.1175371. pmid:19608861
[20]
Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010;327(5968):1000–4. Epub 2010/02/20. doi: 10.1126/science.1179689. pmid:20167786
[21]
Weinert BT, Wagner SA, Horn H, Henriksen P, Liu WR, Olsen JV, et al. Proteome-wide mapping of the Drosophila acetylome demonstrates a high degree of conservation of lysine acetylation. Science signaling. 2011;4(183):ra48. doi: 10.1126/scisignal.2001902
[22]
Lundby A, Lage K, Weinert BT, Bekker-Jensen DB, Secher A, Skovgaard T, et al. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell reports. 2012;2(2):419–31. doi: 10.1016/j.celrep.2012.07.006. pmid:22902405
[23]
Choudhary C, Weinert BT, Nishida Y, Verdin E, Mann M. The growing landscape of lysine acetylation links metabolism and cell signalling. Nature reviews Molecular cell biology. 2014;15(8):536–50. doi: 10.1038/nrm3841. pmid:25053359
[24]
Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem. 2002;277(47):45099–107. Epub 2002/09/26. pmid:12297502 doi: 10.1074/jbc.m205670200
[25]
Avalos JL, Bever KM, Wolberger C. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell. 2005;17(6):855–68. Epub 2005/03/23. pmid:15780941 doi: 10.1016/j.molcel.2005.02.022
[26]
Furumai R, Komatsu Y, Nishino N, Khochbin S, Yoshida M, Horinouchi S. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc Natl Acad Sci U S A. 2001;98(1):87–92. Epub 2001/01/03. pmid:11134513 doi: 10.1073/pnas.98.1.87
[27]
Ekwall K, Olsson T, Turner BM, Cranston G, Allshire RC. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell. 1997;91(7):1021–32. Epub 1998/01/15. pmid:9428524 doi: 10.1016/s0092-8674(00)80492-4
[28]
Fifis T, Scopes RK. Purification of 3-phosphoglycerate kinase from diverse sources by affinity elution chromatography. Biochem J. 1978;175(1):311–9. Epub 1978/10/01. pmid:367367 doi: 10.1042/bj1750311
[29]
Megee PC, Morgan BA, Mittman BA, Smith MM. Genetic analysis of histone H4: essential role of lysines subject to reversible acetylation. Science. 1990;247(4944):841–5. Epub 1990/02/16. pmid:2106160 doi: 10.1126/science.2106160
[30]
Dhar A, Samiotakis A, Ebbinghaus S, Nienhaus L, Homouz D, Gruebele M, et al. Structure, function, and folding of phosphoglycerate kinase are strongly perturbed by macromolecular crowding. Proc Natl Acad Sci U S A. 2010;107(41):17586–91. Epub 2010/10/06. doi: 10.1073/pnas.1006760107. pmid:20921368
[31]
Lallemand P, Chaloin L, Roy B, Barman T, Bowler MW, Lionne C. Interaction of human 3-phosphoglycerate kinase with its two substrates: is substrate antagonism a kinetic advantage? Journal of molecular biology. 2011;409(5):742–57. doi: 10.1016/j.jmb.2011.04.048. pmid:21549713
[32]
Neumann H, Hancock SM, Buning R, Routh A, Chapman L, Somers J, et al. A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation. Mol Cell. 2009;36(1):153–63. Epub 2009/10/13. doi: 10.1016/j.molcel.2009.07.027. pmid:19818718
Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, et al. New nomenclature for chromatin-modifying enzymes. Cell. 2007;131(4):633–6. Epub 2007/11/21. pmid:18022353 doi: 10.1016/j.cell.2007.10.039
[35]
Lahm A, Paolini C, Pallaoro M, Nardi MC, Jones P, Neddermann P, et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A. 2007;104(44):17335–40. Epub 2007/10/25. pmid:17956988 doi: 10.1073/pnas.0706487104
[36]
Robitaille AM, Christen S, Shimobayashi M, Cornu M, Fava LL, Moes S, et al. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science. 2013;339(6125):1320–3. Epub 2013/02/23. doi: 10.1126/science.1228771. pmid:23429704
[37]
Chen RQ, Yang QK, Lu BW, Yi W, Cantin G, Chen YL, et al. CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res. 2009;69(6):2663–8. Epub 2009/03/12. doi: 10.1158/0008-5472.CAN-08-3222. pmid:19276368
[38]
Zhang X, Ozawa Y, Lee H, Wen YD, Tan TH, Wadzinski BE, et al. Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 2005;19(7):827–39. Epub 2005/04/05. pmid:15805470 doi: 10.1101/gad.1286005
[39]
Lee DY, Lee CI, Lin TE, Lim SH, Zhou J, Tseng YC, et al. Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow. Proc Natl Acad Sci U S A. 2012;109(6):1967–72. Epub 2012/02/07. doi: 10.1073/pnas.1121214109. pmid:22308472
[40]
Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124(3):471–84. Epub 2006/02/14. pmid:16469695 doi: 10.1016/j.cell.2006.01.016
[41]
Ojeda L, Gao J, Hooten KG, Wang E, Thonhoff JR, Dunn TJ, et al. Critical role of PI3K/Akt/GSK3beta in motoneuron specification from human neural stem cells in response to FGF2 and EGF. PloS one. 2011;6(8):e23414. doi: 10.1371/journal.pone.0023414. pmid:21887250
[42]
Higuchi M, Proske RJ, Yeh ET. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene. 1998;17(19):2515–24. Epub 1998/11/21. pmid:9824162 doi: 10.1038/sj.onc.1202485
[43]
Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 2003;278(10):8516–25. Epub 2002/12/24. pmid:12496265 doi: 10.1074/jbc.m210432200
[44]
De Koning TJ, Snell K, Duran M, Berger R, Poll-The BT, Surtees R. L-serine in disease and development. Biochem J. 2003;371(Pt 3):653–61. Epub 2003/01/22. doi: 10.1042/bj20021785
[45]
Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R18–36. Epub 2006/08/19. pmid:16917020 doi: 10.1152/ajpregu.00327.2006
[46]
Kumar S, Ma B, Tsai CJ, Wolfson H, Nussinov R. Folding funnels and conformational transitions via hinge-bending motions. Cell Biochem Biophys. 1999;31(2):141–64. Epub 1999/12/11. pmid:10593256 doi: 10.1007/bf02738169
[47]
Banks RD, Blake CC, Evans PR, Haser R, Rice DW, Hardy GW, et al. Sequence, structure and activity of phosphoglycerate kinase: a possible hinge-bending enzyme. Nature. 1979;279(5716):773–7. Epub 1979/06/28. pmid:450128 doi: 10.1038/279773a0
[48]
Bernstein BE, Michels PA, Hol WG. Synergistic effects of substrate-induced conformational changes in phosphoglycerate kinase activation. Nature. 1997;385(6613):275–8. Epub 1997/01/16. pmid:9000079 doi: 10.1038/385275a0
[49]
Flachner B, Kovari Z, Varga A, Gugolya Z, Vonderviszt F, Naray-Szabo G, et al. Role of phosphate chain mobility of MgATP in completing the 3-phosphoglycerate kinase catalytic site: binding, kinetic, and crystallographic studies with ATP and MgATP. Biochemistry. 2004;43(12):3436–49. Epub 2004/03/24. pmid:15035615 doi: 10.1021/bi035022n
[50]
Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W, et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell. 2002;9(1):45–57. Epub 2002/01/24. pmid:11804585 doi: 10.1016/s1097-2765(01)00429-4
[51]
Li J, Wang J, Nawaz Z, Liu JM, Qin J, Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 2000;19(16):4342–50. Epub 2000/08/16. pmid:10944117 doi: 10.1093/emboj/19.16.4342
[52]
Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science. 2001;293(5535):1653–7. Epub 2001/09/05. pmid:11533489 doi: 10.1126/science.1062374
[53]
Thevenet L, Mejean C, Moniot B, Bonneaud N, Galeotti N, Aldrian-Herrada G, et al. Regulation of human SRY subcellular distribution by its acetylation/deacetylation. EMBO J. 2004;23(16):3336–45. Epub 2004/08/07. pmid:15297880 doi: 10.1038/sj.emboj.7600352
[54]
Zeng L, Xiao Q, Margariti A, Zhang Z, Zampetaki A, Patel S, et al. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol. 2006;174(7):1059–69. Epub 2006/09/20. pmid:16982804 doi: 10.1083/jcb.200605113
[55]
Gregoire S, Xiao L, Nie J, Zhang X, Xu M, Li J, et al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol. 2007;27(4):1280–95. Epub 2006/12/13. pmid:17158926 doi: 10.1128/mcb.00882-06
[56]
Chuang HC, Chang CW, Chang GD, Yao TP, Chen H. Histone deacetylase 3 binds to and regulates the GCMa transcription factor. Nucleic Acids Res. 2006;34(5):1459–69. pmid:16528103 doi: 10.1093/nar/gkl048
[57]
Yang HB, Xu YY, Zhao XN, Zou SW, Zhang Y, Zhang M, et al. Acetylation of MAT IIalpha represses tumour cell growth and is decreased in human hepatocellular cancer. Nature communications. 2015;6:6973. doi: 10.1038/ncomms7973. pmid:25925782
[58]
Scott PH, Brunn GJ, Kohn AD, Roth RA, Lawrence JC Jr., Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(13):7772–7. pmid:9636226 doi: 10.1073/pnas.95.13.7772
[59]
Creppe C, Malinouskaya L, Volvert ML, Gillard M, Close P, Malaise O, et al. Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell. 2009;136(3):551–64. doi: 10.1016/j.cell.2008.11.043. pmid:19185337
[60]
Wang YP, Zhou LS, Zhao YZ, Wang SW, Chen LL, Liu LX, et al. Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress. The EMBO journal. 2014;33(12):1304–20. doi: 10.1002/embj.201387224. pmid:24769394
[61]
Stover P, Schirch V. Serine hydroxymethyltransferase catalyzes the hydrolysis of 5,10-methenyltetrahydrofolate to 5-formyltetrahydrofolate. J Biol Chem. 1990;265(24):14227–33. Epub 1990/08/25. pmid:2201683
[62]
Appaji Rao N, Ambili M, Jala VR, Subramanya HS, Savithri HS. Structure-function relationship in serine hydroxymethyltransferase. Biochim Biophys Acta. 2003;1647(1–2):24–9. Epub 2003/04/11. pmid:12686103 doi: 10.1016/s1570-9639(03)00043-8
[63]
Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476(7360):346–50. doi: 10.1038/nature10350. pmid:21760589
[64]
Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nature genetics. 2011;43(9):869–74. doi: 10.1038/ng.890. pmid:21804546
[65]
Labuschagne CF, van den Broek NJ, Mackay GM, Vousden KH, Maddocks OD. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell reports. 2014;7(4):1248–58. doi: 10.1016/j.celrep.2014.04.045. pmid:24813884
[66]
Locasale JW, Cantley LC. Genetic selection for enhanced serine metabolism in cancer development. Cell cycle. 2011;10(22):3812–3. doi: 10.4161/cc.10.22.18224. pmid:22064516
[67]
Vazquez A, Markert EK, Oltvai ZN. Serine biosynthesis with one carbon catabolism and the glycine cleavage system represents a novel pathway for ATP generation. PloS one. 2011;6(11):e25881. doi: 10.1371/journal.pone.0025881. pmid:22073143
[68]
Beutler E. PGK deficiency. British journal of haematology. 2007;136(1):3–11. pmid:17222195 doi: 10.1111/j.1365-2141.2006.06351.x
[69]
Fujii H, Miwa S. Other erythrocyte enzyme deficiencies associated with non-haematological symptoms: phosphoglycerate kinase and phosphofructokinase deficiency. Bailliere's best practice & research Clinical haematology. 2000;13(1):141–8. doi: 10.1053/beha.1999.0062
[70]
Turner G, Fletcher J, Elber J, Yanagawa Y, Dave V, Yoshida A. Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred. British journal of haematology. 1995;91(1):60–5. pmid:7577653 doi: 10.1111/j.1365-2141.1995.tb05245.x
[71]
Ramirez-Bajo MJ, Repiso A, la Ossa PP, Banon-Maneus E, de Atauri P, Climent F, et al. Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation. Blood cells, molecules & diseases. 2011;46(3):206–11. doi: 10.1016/j.bcmd.2010.12.009
[72]
Vulliamy T, Beutler E, Luzzatto L. Variants of glucose-6-phosphate dehydrogenase are due to missense mutations spread throughout the coding region of the gene. Human mutation. 1993;2(3):159–67. pmid:8364584 doi: 10.1002/humu.1380020302
[73]
Guan KL, Yu W, Lin Y, Xiong Y, Zhao S. Generation of acetyllysine antibodies and affinity enrichment of acetylated peptides. Nature protocols. 2010;5(9):1583–95. doi: 10.1038/nprot.2010.117. pmid:21085124
[74]
Krietsch WK, Bucher T. 3-phosphoglycerate kinase from rabbit sceletal muscle and yeast. European journal of biochemistry / FEBS. 1970;17(3):568–80. pmid:5493986 doi: 10.1111/j.1432-1033.1970.tb01202.x
[75]
Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452(7184):230–3. Epub 2008/03/14. doi: 10.1038/nature06734. pmid:18337823
[76]
Zerez CR, Lee SJ, Tanaka KR. Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Analytical biochemistry. 1987;164(2):367–73. pmid:3674385 doi: 10.1016/0003-2697(87)90506-9
[77]
Wagner TC, Scott MD. Single extraction method for the spectrophotometric quantification of oxidized and reduced pyridine nucleotides in erythrocytes. Analytical biochemistry. 1994;222(2):417–26. pmid:7864367 doi: 10.1006/abio.1994.1511
